Please see Important Safety Information and full Prescribing Information, including Boxed Warning, at www.AUSTEDOhcp.com.
This information in intended for US Providers only. AUSTEDO XR is a Teva Neuroscience, Inc. brand and is not associated with any individual users on LinkedIn.
Follow this page to stay up to date with the latest information about AUSTEDO XR.
See our full Terms of Use here:
https://www.austedosocialmedia.com/terms-of-use
AUS-46454 July 2024
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.AUSTEDOhcp.com
Austedo® Xr (Deutetrabenazine) Extended-Release Tablets Questions
Austedo® Xr (Deutetrabenazine) Extended-Release Tablets's website is https://www.AUSTEDOhcp.com
Austedo® Xr (Deutetrabenazine) Extended-Release Tablets's LinkedIn profile is https://www.linkedin.com/company/austedoxr
Austedo® Xr (Deutetrabenazine) Extended-Release Tablets's industry is
Pharmaceutical Manufacturing
Austedo® Xr (Deutetrabenazine) Extended-Release Tablets's top competitors are
Abbvie,
Teva Pharmaceuticals,
Keystone In Home Care Inc,
Neurocrine Biosciences,
Intra-Cellular Therapies,
Kisqali Hcp,
Amgen,
Orchid Wellness,
Keytruda® (Pembrolizumab) Hcp,
Quviviq® (Daridorexant).
Austedo® Xr (Deutetrabenazine) Extended-Release Tablets's categories are Pharmaceutical Manufacturing
